METHOD OF STABILIZING AN ENZYME SOLUTION FOR USE IN TOTAL CHOLESTEROL DETERMINATION, STABILIZED SOLUTION AND TEST KIT THEREFOR

Abstract: Stabilized enzymes useful in the diagnostic assay of total cholesterol are prepared by dissolving a salt of cholic acid in a buffer solution providing a pH within the range of about 4 to about 9, to the solution is added a cholesterol esterase. The solution is then mixed with a polyhydroxy organic compound and TRITON-X-100. A cholesterol oxidase and a peroxidase are each dissolved in separate portions of buffer solution and introduced into the buffered solution containing the choles­ terol esterase, 4-aminoantipyrine is then added to the solu­ tion. The resultant solution is a stabilized enzyme solution which can be used in the total cholesterol assay of a serum sample. The stabilized solution can be used in combination with a chromogen diluent solution which is made by dissolv­ ing phenol and TRITON-X-100 in water or a buffer solution. The combination of the stabilized enzyme solution and the chromogen diluent solution provides a solution which has utility in the spectro-photometric assay of total cholesterol.

Description: ENZYMATIC METHOD, STABLIZED SOLUTIONS AND EI'1'S FOR DETERMINING TOTAL CHOLESTEROL TN HUMAN SERUM Background of the Invention The present invention relates to a method for deter-. mining cholesterol, either total cholesterol or bound cholesterol, in human serum. ore particularly, the invention relates to a method and stabilized nzymatic solutions for use in the method in determining the total cholesterol in serum. Cholesterol is present in biological ntter, such as serum and the like, partially in free form and partially in bound form as a cholesterol ester For the determination of total cholesterol, it is necessary to release the cholesterol that is bound in cholesterol ester form. The releasing of the bound cholesterol has been conducLed through saponification of the cholesterol ester rider alkaline conditions using alcoholic potash lye for example Following the saponification, the released cholesterol can then be determined either chemically or enzymatically by one of the known methods. A chemical cietermination may be performed, for example, by the Liebermann-Burchard method. An enzymatic determination may be performed by means using cholesterol oxidase, cholesterol esterase, or cholesterol dehydrase. The alkaline saponification of bound cholesterol is a troublesome and time consuming step in the overall assay of total cholesterol. Furthermore, the relatively aggressive reagents used may lead to a decomposition of the cholesterol. In order to prevent such decomposition and inhibit the determining of false and/or imprecise results of the analysis, a hydrolysis must generally be performed under relatively mild conditions. This, in turn, undesirably increases the length of time required for the cholesterol determination. The alkaline liberation of the bound cholesterol is especially: disadvantageous when the determination of the cholesterol is to be performed by the preferred enzymatic methods. Since the enzymes are inactivated in the strongly alkaline medium, the hydrolyzate must be neutralized by the addition of acid to a pH of about 5 to 8 before the enzymatic determination can be initiated. This extra step results in the addition of more time in the overall determination of the total cholesterol. It is also known that bound cholesterol can be freed by the action of enzymes, cholesterol esterases, which break the ester bond in cholesterol esters. Such cholesterol esterases were isolated initially from animal sources, such as from pork pancreas and rat pancreatic juice. It is also known that in addition to cholesterol esterases being found in the pancreas, that cholesterol esterases can be found in the liver. Allain, et al. describe an enzymatic method for the determination of total serum cholesterol using a cholesterol esterase isolated from pork pancreas and rat pancreatic juice. "Clinical Chemistry," 20 (1974), 470-475. In the method of Allain, et al. the cholesterol esterase (cholesterol ester hydrolyase), freed the esterified cholesterol. The resulting freed cholesterol was treated with cholesterol oxidase to form cholestenone and hydrogen peroxide. The resulting hydrogen peroxide was measured quantitatively using spectrophotometric methods. The hydrogen peroxide reacted with 4-aminoantipyrine and phenol in the presence of a peroxidase to form a quinoneimine dye. Allain, et al. utilized one aqueous buffered solution to conduct the cholesterol determinations. Cholesterol esterases are known labile compounds that are generally unstable in aqueous solutions. Allain, et al. state that the enzyme solution used in their method is unstable having a stability of eight hours at room temperature (250C) and 24 hours at refrigerated temperatures of 4"C. United States Patent No. 3,925,164 to Beauchamp, et al. also describes a method for the enzymatic determination of total cholesterol in serum. The method therein treats the serum sample with a cholesterol esterase to release the bound cholesterol. The total cholesterol is then determined by known techniques. The method utilizes a cholesterol esterase produced from a microorganism rather than using a cholesterol esterase produced from an animal source. The patent states that the microorganism produced cholesterol esterase is preferred over cholesterol esterase produced from animal sources in the complete saponification of cholesterol esters in the framework of a quantitative analysis process because the cleavage rates for animal source cholesterol esterases were not quantitative. Furthermore, bound cholesterol is present in biological matter in the form of widely different acids. For an enzymatic process to be useful in the framework of a process of quantitative analysis, it is required that all of the esters that may occur be cleaved quantitatively with approximately the same speed and with the same reliability. Many of the known animal-source cholesterol esterases are somewhat specific toward specific cholesterol esters. The activity of such cholesterol esterases is known to vary with regard to various cholesterol esters. Although the cholesterol esterases produced from microorganisms offer advantages over those produced from animal sources, the microorganism-produced cholesterol esterases also are labile compounds that tend to undergo chemical change in solution and especially in aqueous solutions, which decreases their enzymatic activity. Stability of enzymatic solutions used in diagnostic assays is important in providing methods of analysis which exhibit precision and uniformity among separate determinations when conducted over a period of elapsed time. Instability of enzymatic solutions, in addition to not providing reproducibility of assays, can also add to the ever increasing cost of medical services because the unstable enzymatic solutions need to be discarded and fresh solutions formulated. It has recently been estimated that about 25 percent of all in vitro diagnostic tests conducted annually in the United States are unreliable. Unreliable tests can result in unnecessary medical treatment, the withholding of necessary treatment and lost income. Because of their high specificity, the use of enzyme determinations has significantly increased during the last few years and indications are that this trend will continue. However, rigorous quality control measures are required to assure the accuracy and consistency of results. This requirement derives from the fact that the exact nature of enzymes, as well as mechanisms of their reactions1 remains unknown for the most part. At present, the greatest limitation in the diagnostic reagent manufacture, by far, lies in the unstable characteristics of the enzymatic solutions. Current cholesterol diagnostic methodologies require the use of labile ingredients whether utilizing enzymes from microorganisms or animal source. Due to the labile nature of the enzymes, rigorous quality control is required over the production of such enzymatic solutions and in the reconstituting dry media preparations and formulation of such enzymatic solutions. Such quality control is costly. Moreover, if such control in any step in the process is not maintained within a high degree of control standards, the quality of the final product can be reduced materially leading to decreased precision in-assay results. The present commercial state-of-the-art used for stabilizing the reactive ability of enzymes or coenzymes is by locking them into a solid matrix, either by freeze drying, dry blending such as used for tableting dry powders primarily in the pharmaceutical diagnostic and related industries, and immobilization by locking the chemical structure of the enzyme into a solid matrix. Contrary to the sophistication these terms imply, these approaches are neither practical nor desirable and are also expensive. The manufacturer is forced to remove the water and supply a partial product, thus relinquishing part of the quality control cycle in the dilution and use of the final product. Laboratories are forced to pay the high cost of packaging, reagent waste, freeze drying and dry blending. Usefulness of the product is further limited by packaging modes and sizes. Furthermore, good product uniformity is difficult to achieve, especially in the laboratories where the products are to be utilized in diagnostic assay. This condition is exemplified by the fact that most commercial freeze-dried controlled sera (reference serum) lists the acceptable bottle-to-bottle variation of enzyme constituents at f10 percent of the mean. The present invention is uniquely designed so that the enzyme solution, although containing labile inyredients in a liquid reagent, are effectively "stabilized" thereby controlliny the activity of the labile ingredients in the liquid solution. The means of stability insures long-term stability in a liquid media. Moreover, close tolerance control can be achieved in the manufacturing of a high quality product which eliminates the inconvenience of the rigid package size, the high cost of packaging and freeze drying, and reagent waste. Summary of the Invention Labile enzymes,useful in the diagnostic assay of total cholesterol in serum, are treated according to the invention resulting in long-term stability without deleteriously affecting enzyme activity or photometric absorptivity. The invention provides reagents wherein quality control is assured throughout manufacturing, packaging, storage, and the use. The inconvenience of rigid package size is eliminated as is the high cost of packaging, freeze drying, and reagent waste. The liquid enzyme system for total cholesterol assay, as described herein, provides desired flexibility to total cholesterol assay determination. The stabilized enzymes of the invention have been assessed in studies which compared the liquid stabilized enzyme solutions with fresh reagents. The studies show a one-to-one correlation between aged liquid and fresh reagents with comparable sensitivity and precision. Providing reagents of this type in a stable liquid form enhances the color of spectrophotometric capability of present-day methodologies, as well as other non-color methodologies. The stable liquid enzymes for total cholesterol determination are especially advantageous where oxygen consumption and/or hydrogen peroxide production and consumption are the bases of measurement. The liquid system of the present invention also offers better reagent homogeneity and packaging, as well as flexibility and usage, in contrast to the freeze dried or dry media preparations. In diagnostic cholesterol assay, the stabilization of the labile components and particularly the labile cholesterol esterases in a ready-to-use liquid media, is a new and exciting approach to satisfy the needs of the clinical laboratory and the reliability demands of the regulatory authorities. The flexibility of these liquid systems insures their applicability to automated instrumentation, as well as their convenience in manual testings. Stabilization of the enzymes useful in the determination of total cholesterol in serum is accomplished, in accordance with the invention, by dissolving the sodium salt of cholic acid in a buffer solution capable of maintaining the pH within the range of about 6 to about 8. The cholesterol esterase is added to the cholic acid dissolved in the buffer solution. The resultant mixture is thoroughly intermixed. TRITON-X-100 and glycerol are added. A cholesterol oxidase is dissolved in a separate portion of the buffer solution and added to the mixture. A peroxidase is also dissolved in a separate portion of the buffer solution and added to the mixture. 4-aminoantipyrine is then introduced and dissolved in the mixture. The resultant enzyme solution can then be dispensed into appropriate bottles for storage and subsequent use. Projected shelflife of the solution in this form is from about two years to about three years. The above enzyme solution is used in total cholesterol determinations by combining the above enzyme solution with a chromogen diluent. The diluent solution contains an appropriate color-producing agent useful in the assay of total cholesterol. A suitable color-producing chromogen diluent solution can be formulated by combining TRITO-X-100 with phenol and water. The water can be provided in a buffer solution which maintains the pH of the chromogen diluent within the same range as the above enzyme solution, such as a pH 6 to about 8. When the above enzyme solution is combined with the chromogen diluent, the resultant solution can be used directly in the assay of total cholesterol. The combined solutions have a shelf-life of about one year under refrigerated conditions. Of course, when the total cholesterol assay is to be determined through means other than colorimetrically, the chromogen diluent solution is not necessary. In methods using oxygen consumption analysis, the above enzyme solution need only be diluted with water to have utility. In addition no peroxidase need be added. These and many other features and attendant advantages of the invention will become apparent as the invention becomes better understood by reference to the following detailed description. Detailed Description of the Invention The method and stabilized solutions described herein can be used in the clinical diagnostic field for the deter mination of total cholesterol in serum. The following chemical reaction sequence illustrates the methodology of total cholesterol determination using the stabilized solutions herein: (I) Cholesterol Esters Cholesterol Esterase Cholesterol + Fatty Acid H20 (II) Cholesterol + 2 1 ¯ Cholesterol Oxidase Cholest-4-en-3-one + H202 In the cholesterol assay method illustrated by the above reaction sequence, cholesterol ester bonds are split by the cholesterol esterase to form free cholesterol and the appropriate fatty acid. The cholesterol then reacts with oxygen in the presence of cholesterol oxidase to form the ketone cholest-4-en-3-one and hydrogen peroxide. It is the reaction sequence (II) above that has been developed for quantitative measurements for determining the amount of cholesterol present in a serum sample. Generally, the quantitative determination of cholesterol can be made by measuring the production of hydrogen peroxide or the con gumption of oxygen. When the production of hydrogen peroxide is used, generally a color-produciny agent is used which reacts with the hydrogen peroxide to produce a chromogen providing color which is measurable quantitatively by spectrophoto metric analysis. A particularly preferred method of measuring the production of hydrogen peroxide using the stabilized enzyme solutions herein is by using 4-aminoantipyrine and phenol which combines with hydrogen peroxide in the presence of a peroxidase to form a chromogen by the following reaction sequence: EMI10.1 The chromogen produced has a maximum absorption at 500 nm. The intensity of light absorption at this wavelength can provide for the quantitative amount of hydrogen peroxide which, in turn, can be correlated through stoichiometric calculation to the amount of cholesterol initially present. When cholesterol analysis is made by measuring the consumption of oxygen, the rate of oxygen comsumption can be measured by an instrument which relates the amount of oxygen consumed to the total cholesterol concentration. The rate. of oxygen consumption may be measured colorimetrically, however, it can also be measured using an oxygen electrode. An instrument for measuring the consumption of oxygen utilizing an oxygen electrode is available commercially from Beckman Instruments, Inc., a Cholesterol Analyzer 2. The oxygen electrode responds to oxygen concentration in the samle/reagent solution into which it is immersed. The oxygen electrode is a polargraphic electrode in that it measures a current limited by the diffusion of oxygen through a membrane to the cathode. A stable, fixed thickness of an electrolyte gel is maintained between the membrane and cathode. The amount of oxygen which diffuses through the membrane is proportional to the oxygen concentration in the solution. Associated electronic circuitry differentiates the electrode output. signal providing a signal which is proportional to the rate of oxygen consumption and, thereby, to the cholesterol concentration. The oxygen consumption rate analysis is advantageous in that an instrument is commercially available which can determine and provide a direct readout of cholesterol concentration. This method also eliminates the need for a chromogen producing reaction and avoids potential interference with chromogen systems that can arise because of the presence of other colored substances within a serum sample or due to the presence of reducing substances reacting with hydrogen peroxide. The stabilized enzyme solutions herein have applicability in both the chromogen (spectrophotometric) and oxygen consumption methods of total cholesterol determination. When the stabilized solutions herein are to be used in a spectrophotometric analysis, the enzyme solutions can be prepared as two separate reagents or as a concentrate. In the two-reagent system the first reagent, the enzyme concentrate, comprises the enzymes: cholesterol esterase; cholesterol oxidase and peroxidase in a stabilized solution in combination with providing one of the compounds, which upon coupling, forms the color producing chromogen. The second reagent, the chromogen, is also the diluent for the first reagent and comprises the second compound which upon coupling with the first in the presence of hydrogen peroxide and peroxidase, provide the color yielding chromogen. The two separate reagents are combined to determine cholesterol concentration in serum. The two reagents have a stability, when uncombined, of about six months to one year at room temperature and two to three years under refrigeration (X4 C) for the first reagent (concentrate) and a substantially longer lifetime for the essentially non-degradable second reagent (chromogen). When combined, the resulting mixture has a stability generally greater than state-of-the-art solutions of about 6 to about 12 months under refrigeration, about two to three months at room temperature, about one week at about 3701 and up to about 24 hours at about 41"C. When the cholesterol assay is to be determined by oxygen consumption only one enzyme solution is needed as the determination is not predicated on the formation of color. In the oxygen consumption method of assay, the enzyme solution comprises a solution similar to the first reagent (concentrate) described with regard to the spectrophotometric assay method. That is, the enzyme solution comprises the enzymes: cholesterol esterase and cholesterol oxidase in a stable solution. Such a stabilized solution can be diluted with water prior to use, or supplied in a final diluted form and used directly It has been found that the enzyme solutions herein have and retain sufficient activity to provide good precision and assay of cholesterol when formulated by the method described hereinafter. For ease of description of the stabilized solutions, the solutions will be described herein with regard to the method in which they are to be utilized. The buffer solutions used in formulating the reagents herein comprise a buffer solution which is capable of maintaining the pH of the reagent within a range from about 4 to about 9. A preferred buffer is prepared by dissolving potassium dihydrogen phosphate in water and adding sodium hydroxide to provide the desired pH within the above range. A particularly preferred pH for such a formulated buffer solution is a pil of about 6.60. The buffer is selected which provides the proper pH ranges and which does not materially interfere with the enzyme activity or the reactions occurring within the cholesterol assay determination. The above-described potassium dihydrogen phosphate buffer solution is particularly preferred because it provides a pH within the desired range and does not otherwise interfere with any of the enzyme reactions occurring in the cholesterol determination. In the spectrophotometric analysis of a sample serum, the reagent containing the enzymes is prepared by dissolving the cholesterol esterase in the buffer solution having a pH within the range of about 4 to about 9. The sodium salt of cholic acid is added to assist in dissolving the cholesterol esterase in the buffer solution, and to assist in breaking up the lipoproteins in the sample which contains esters of cholesterol. Any metal salt such as an alkali metal salt of cholic acid can be used, however, the sodium salt is preferred because it is readily available commercially and the presence of the sodium ion in the solution does not deleteriously affect the solution nor the cholesterol assay. The sodium salt of cholic acid (sodium cholate) is added to the mixture of cholesterol esterase and buffer solution to provide activation of the cholesterol esterase and other enzymes to be added, to assist in the stabilization of the resulting enzyme solution, and to break up lipoproteins present in serum samples, during assay. Sodium cholate is available commercially and the commercially available sodium cholate is acceptable for use in the solutions described herein. However, the commercial preparations of sodium cholate contain some impurities which can tend to deactivate the enzymes and which can also tend to decrease the absorbance of the chromogen formed. For this reason, it is desirable to use a small amount of sodium cholate when formulating the enzyme solution. For example, sodium cholate is used in an amount up to about 2.25 g for each 150 ml of the final volume of enzyme solution. It is preferred to use about 0.750 g for each 150 ml of final enzyme solution. Such an amount of sodium cholate does not inhibit the enzyme activity to any substantial degree. The cholesterol esterase can be any cholesterol esterase but it is preferred that the cholesterol esterase be produced from a microbial source. Such microbial produced cholesterol esterase is preferred because it has better stability and activity in the assay media than a cholesterol esterase produced from an animal source. In addition, the cholesterol esterase from a microbial source is preferred because cholesterol esterase from animal sources is generally contaminated with proteases which can react with cholesterol oxidase used in the cholesterol determination method thereby destroying the cholesterol oxidase and making it unavailable for reacting with cholesterol to produce the cholestenone. A preferred cholesterol esterase is a cholesterol esterase produced from pseudornonas fluorescens. The preferred cholesterol esterase is obtained from pseudomonas fluorescens ATCC 21156 commercially available from Kyowa EIakko Kogyo Company, Ltd. The cholesterol esterase can be used in any amount to provide the desired activity in the enzyme solution. The activity of the cholesterol esterase desired is that amount which will provide an activity in the final enzyme solution which is sufficient to complete the deesterification of cholesterol esters in a time of about ten minutes at a temperature of about 37"C. Such an amount of cholesterol esterase can be about 150 IU for 150 ml of enzyme concentrate solution or about 1000 IU per liter of the diluted solutions used in the spectrophotometric assay. Cholesterol esterases can also be obtained from microorganisms other than pseudomonas fluorescens, for example, cholesterol esterases can be obtained from microorganisms, as described in United States Patent No. 3,925,614 of Beauchamp, et al., which is incorporated herein by this reference. Following the mixing of cholesterol esterase, sodium cholate and buffer solution, the mixture is allowed to stand under refrigeration for about 24 hours. The mixture is thoroughly mixed to obtain a homogeneously opaque solution. To this solution is added a polyhydroxy compound, such as ethylene glycol, propylene glycol and glycerol. Glycerol is particularly preferred as the glycerol does not inhibit the enzyme activity, nor does it deleteriously affect the cholesterol assay. The polyhydroxy compound is used in an amount which provides about one-half the volume of the enzyme solution. The amount of polyhydroxy compound can be greater but such higher amounts can reduce the enzyme activity and thereby make the cholesterol assay completion time longer. Greater amounts of the polyhydroxy compound also can increase the viscosity of the enzyme solution thereby making analysis by instrumental means more difficult. In addition to the polyhydroxy compound, there is added an alkyl aryl polyether alcohol, TRITON-X-100 (a registered trademark product of Rohm & Haas, Co.). TRITON-X-100 is commercially available from Eastman Kodak Co. and J. T. Baker Chemical Co. TRITOr4-X-100 is a polyethylene glycol, p-isooctylphenyl ether, CAS registry No. 9002-93-1. For the purposes of the stabilized solutions herein, the commercially available TRITON-X-100 is acceptable. Especially acceptable is the scintillation grade TRITON X-100 commercially available from J. T. Baker Chemical Co. and sold under the commercial name LSC Non-Ionic Surfactant Scintrex. The TRITON-X-100 can be added in an amount which will provide up to about 0.5 percent by volume in the final enzyme solution. An amount of TRITON X-100 greater than about 0.5 percent by volume can be used, however, as the TRITON-X-100 is a surfactant, an amount greater than 0.5 percent can create excessive foaming and thereby an amount greater than 0.5 percent is undesirable. Generally, an amount of TRITON-X-100 greater than 0.3 percent by volume does not significantly increase the activity or increase the completion rate of the cholesterol assay. The TRITON-X-100 used in an amount at least about 0.1 percent by volume does activate, i.e., increase the activity of the cholesterol esterase and it has been found that the activity of cholesterol esterase from pseudomonas fluorescens exhibits a reduced activity when amounts of TRITON-X-100 are less than 0.1 percent by volume. Although not to be held to the theory herein, Applicant theorizes that amounts of TRITOrk-X-100 greater than 0.1 percent by volume breaks up the lipid characterization of the crude cholesterol esterase thereupon activating the cholesterol esterase. Following the addition of the polyhydroxy compound and TRIT0N-X-100, a cholesterol oxidase is added to the solution. The cholesterol oxidase is first dissoled in the buffer solution and the dissolved cholesterol oxidase is then added to the enzyme solution. The cholesterol oxidase is preferably product from microorganism sources. Cholesterol oxidases from non-microbial sources, such as animal sources, exhibit a much reduced activity in the assay media described herein for cholesterol. The microorganisms from which an acceptable cholesterol oxidase can be produced are pseudomonas sp, nocardia erythropolis and brevibacterium stero licum. Cholesterol oxidases from these microorganisms are commercially available and for the purposes of the solutions herein the commercially available cholesterol oxidases are acceptable. Although acceptable enzymes are obtained from the above microorganisms, the activity of the cholesterol oxidase in the enzyme solution depends upon the source of the cholesterol oxidase and the pH of the assay media. For the enzyme solution herein, the preferred cholesterol oxidase source is nocardia erythropolis. Such a cholesterol oxidase is commercially available from Whatman Chemical Co. The cholesterol oxidase from nocardia erythropolis is preferred as it exhibits a maximum activity at a pH of about 5 to about 9 and preferably between a pH range from about 6 to about 8. The cholesterol oxidase from nocardia erythropolis is especially stable and retains its activity in the enzyme solution herein. The cholesterol oxidase from pseudomonas sp has its maximum activity at a pH of about 5. The cholesterol oxidase produced by brevibacterium stero licum has its maximum activity at a pH of about 6. As with the cholesterol esterase, the cholesterol oxidase can be used in any amount. However, it is preferable to use the minimum amount of cholesterol oxidase for economic reasons. Larger amounts of cholesterol oxidase increase the rate of reaction and, therefore, decrease the time required to perform a total cholesterol assay. Because of the stabilizing effect of the solution herein, it has been found that the cholesterol oxidase can be present in an amount of about 300 to about 1000 IU/1 of the enzyme concentrate and preferably 500 to about 750 IU/1. This amount of cholesterol oxidase is sufficient to provide a time of about ten minutes for a cholesterol assay at a temperature of about 370C. The peroxidase is also dissolved in a portion of the buffer solution and added to the buffered enzyme solution. A suitable peroxidase can be isolated from horseradish. Such peroxidase from horseradish is commercially available and the commercially available peroxidase is acceptable for the solutions herein. Such a peroxidase from horseradish source is available from Beckman Instruments, Inc. The peroxidase can be used in an amount such that the chromogen formation is instantaneous as the enzyme is relatively inexpensive. It is preferred to have a sufficient amount of peroxidase such that the hydrogen peroxide formed is reacted and consumed by the peroxidase substantially instantaneously and thereupon avoid any side reactions of the hydrogen peroxide. In this manner the overall schematic of the reaction is efficiently quantitative for the cholesterol determination. Generally, an amount of peroxidase of about 22.5 to about 45 KU per 150 ml of enzyme solution (equivalent to 750 ml final reagent), is sufficient to provide the instantaneous reaction with hydrogen peroxide. To the formulated enzyme solution containing cholesterol esterase, cholesterol oxidase and peroxidase is added a compound capable of coupling through the reaction of the peroxidase and hydrogen peroxide with another compound to produce a chromogen. Only one of the compounds capable of coupling is added to the enzyme solution. The preferred compound to be added to the enzyme solution is 4-aminoantipyrine. 4-aminoantipyrine is capable of coupling with phenol in the presence of hydrogen peroxide and a peroxidase to produce a quinoneimine dye. The amount of 4-aminoantipyrine is from about 22.5 to about 67.5 mg per 150 ml total enzyme solution. It was found that 4-aminoantipyrine tends to inhibit the overall enzyme reaction during the cholesterol assay, as well as tending to have a destabilizing effect on the color of the chromogen produced. That is, when a greater amount of 4-aminoantipyrine is used, the more the color of the chromogen will fade and absorbance will increase at the peak absorbance of the quinoneimine dye which is at 500 nm. If less 4-aminoantipyrine is used, there is exhibited a less adverse effect on the final color, however, reduciny 4-aminoantipyrine below the preferred range tends to reduce the useful dynamic range of the procedure because an insufficient amount of 4-aminoantipyrine is present to react stoichiometrically with the hydrogen peroxide produced. The resultant enzyme-containing solution can be used in the spectrophotometric assay of total cholesterol in a serum sample. This solution is referred to as the enzyme concentrate solution as it contains the enzymes which bring about the reaction sequence leading to the determination of cholesterol. This solution has been found to be stable with the enzymes contained therein retaining about 90 percent of their activity for about two years under refrigerated temperatures (about 40C) and for about four months at about room temperature. When the enzyme concentrate solution is to be used in the spectrophotometric assay of total cholesterol, it needs to be combined with a second reagent which contains the other compound capable of coupling with the 4-aminoantipyrine and hydrogen peroxide to form a quantitatively measurable color. Such a second reagent is formed by dissolving phenol and TRITON-X-100 in water. The phenol reacts in accordance with the above-reaction sequence with the 4-aminoantipyrine and hydrogen peroxide to produce the quinoneimine dye. The amount of phenol in the second reagent is sufficient to provide for the instantaneous reaction of the hydrogen peroxide formed. However, too great a phenol concentration is undesirable as phenol tends to denature proteins in aqueous medium. Additionally, high concentrations of phenol can affect the stability of the combined reagents (enzyme concentrate and second reagent) as the phenol can react in side reactions which can produce colors even though no cholesterol is present. That is, the combined enzyme concentrate solution and second reagent can have a color due to side reactions initiated by the phenol. Preferably, the phenol concentration is from about 0.75 to about 2.25 g for 1.5 liters of the second reagent formed. Such a concentration of phenol has been found to be efficacious in the instantaneous reaction of the hydrogen peroxide formed during the cholesterol assay without substantially interfering with the colorimetric assay method or without deleteriously denaturing proteins present in the serum being treated or otherwise affecting the stabilized cholesterol assay solutions. The water used in the solutions described herein is preferably deionized or distilled water or both. Using such deionized and/or distilled water is preferred to avoid contaminating the solution with impurities which can be present in tap water. Although tap water used by the author also yielded accurate results. In the total cholesterol assay determination using colorimetric and spectrophotometric analysis, the enzyme concentrate solution is combined with the second reagent (chromogen producing reagent) prior to conducting the assay on a serum sample. The two solutions are combined and thoroughly intermixed prior to the assay determination. The combined mixture also exhibits a stability greater than the state-of-the-art cholesterol assay solutions. The conbined mixture herein exhibits a stability of about 6 to about 12 months under refrigeration temperatures (2 to 80C) about two to three months at room temperature, about one week at 370C, and about 24 hours at 410C. The combined mixture has an initial absorbance generally less than about 0.200 and is a clear slightly reddish solution containing no solids. The pH of the combined solutions remains within the pH range of about 4 to about 9 and preferably about 6.6 +0.2. In the total cholesterol assay of a serum sample, the enzyme concentrate solution is combined with the second reagent to produce a combined substrate solution. An aliquot of this combined substrate is combined with an aliquot of the serum sample. The, two aliquots are thoroughly intermixed and incubated at about 370C for a time sufficient to allow reaction in the production of the quinoneimine dye. Generally, this time is preferably about 5 to 15 minutes. The time for the reaction is, as discussed above, dependent upon the media- pH, the concentration of enzymes, cholate, TRITON-X-100, 4-aminoantipyrine and phenol. Alternatively, rather than combininy the enzyme concentrate and second reagent to form a combined substrate solution, aliquots from each of the enzyme concentrate solution, second reagent, and serum sample can be combined and thoroughly intermixed and allowed to incubate for the necessary time period at about 37"C. Following the incubation period there is produced a color characteristic of the quinoneimine dye. The color produced is stable for about one-half hour to one hour. Spectrophotometric analysis is conducted using techniques of spectrophotometric analysis known to those skilled in the art. As is apparent to those skilled in the art, a blank is formed comprising the combined substrate solution. Using the blank solution, the spectrophotometer is adjusted to the combined substrate are then placed in the spectroshoto- meter and the absorbance for each sample is measured. The absorbance for each sample can be correlated to obtain the concentration of cholesterol therein. As stated above, the color produced in the assay media is stable for about one-half hour to one hour at room temperature which allows for ease of analysis. The spectrophotometric analysis is calibrated by measuring absorbance of solutions of known cholesterol levels. Calibration is perfected by mixing the combined substrate with sairples of known cholesterol levels and measuring the absorbance for these samples. A calibrated curve is then plotted of concentration versus absorbance. The serum sample to be analyzed can ten be analyzed and its absorbance fitted to the calibrated curve to determine the total cholesterol concentration within the serum sample. In addition to utilizing two solutions for the spectrophotometric assay of total cholesterol in serum, there can be produced one reagent containing the necessary corlaonents in a concentrate or in a final diluted form. When one solution is to be utilized, it should be kept in a container or storage area away from light to prevent increased blank absorbance. It has been found herein that such a one reagent comprising an enzyme concentrate can be formed which has a stability greater than such solutions known in the present state-of-the-art. The enzyme concentrate solution of long stability need be only diluted with water prior to use or may be supplied in the final diluted form with stability of up to one year in the spectrophotometric analysis of cholesterol in serum samples. When a single reagent is to be employed, it can b formulated by dissolving a salt of cholic acid, such as sodium cholate in a suitable buffer solution having a pH of about 4 to about 9. A suitable buffer solution is a potassium dihydrogen phosphate and sodium hydroxide buffer solution providing a pH of about 6.60. Also dissolved in the buffer solution is the cholesterol esterase. Any suitable cholesterol esterase can be utilized, however, it is preferred to use a cholesterol esterase from a microbial source and, more preferably, from pseudomonas fluorescens, as described above with regard to the tworeagent system of total cholesterol assay. The components are thoroughly intermixed and allowed to stand under refrigeration for about 24 hours to insure thorough mixing. To the solution is added a polyhydroxy compound, such as glycerol, ethylene glycol and propylene glycol in an amount up to about one-half the volume of the final concentrate solution to be formed. A preferred polyhydroxy compound is glycerol. A cholesterol oxidase is dissolved in a sufficient amount of the buffer solution and introduced into the mixture. The cholesterol oxidase can be any suitable cholesterol oxidase but is preferably a microbial produced cholesterol oxidase. Cholesterol oxidase produced from animal sources does not exhibit the stability of cholesterol oxidase from microbial sources. The preferred microbial sources for cholesterol oxidase are nocardia erythropolis, pseudomonas sp and brevibacterium stero licum. The amount of cholesterol oxidase added depends upon the selection of the cholesterol oxidase and the source from which it is derived. The cholesterol oxidase from nocardia erythropolis is preferred because it retains its maximum activity at a pH range from about 5 to about 9 and even retains better activity at a ptI range from about 6 to about 8. The amount of cholesterol oxidase utilized is selected based upon economic considerations as the greater amount of cholesterol oxidase utilized decreases the reaction time for the total assay of cholesterol. Preferably, an amount of cholesterol oxidase, as well as cholesterol esterase, is selected which will provide a complete reaction in about two to ten minutes at about 37or. A peroxidase is also dissolved in a sufficient amount of the buffer solution and introduced into the enzyme concentrate solution. The peroxidase can be any suitable peroxidase and is preferably a peroxidase from horseradish source. The amount of peroxidase utilized is an amount sufficient to provide an instantaneous reaction with the hydrogen peroxide produced during the reaction sequence. By providing an instantaneous reaction with the hydrogen peroxide produced, there is avoided any side reactions of the hydrogen peroxide which could affect the specificity of the analysis. During the addition of the polyhydroxy compound, there is also added TRITON-X-100 in an amount between about 0.1 to about 0.5 percent by weight. Such an amount of the TRITO-X-100 provides sufficient stability of the enzymes in the solution without providing undesirable surfactant characteristics to the resultant solution. Following the addit-ion of the cholesterol oxidase and peroxidase, there is added to the enzyme concentrate solution 4-aminoantipyrine. The 4-aminoantipyrine is one of the chromogen producing compounds which reacts with the hydrogen peroxide formed and phenol in the presence of the peroxidase to produce the chromogen or color-producing compound (quinoneimine dye). The amount of 4-aminoantipyrine is sufficient to react stoichiometrically with the hydrogen peroxide produced. Preferably, a stoichiometric excess ot such 4-aminoantipyrine is used. The upper limit of the amount of 4-aminoantipyrine is. dependent on the destabilizing effect of the 4-aminoantipyrine on the color produced, i.e., the 4-aminoantipyrine at relatively higher concentrations than the stoichiometric concentrations tend to make the color produced fade at the peak absorbance of about 500 nm for the chromogen produced. After the addition of the 4-aminoantipyrine, phenol is added to the enzyme concentrate solution as the second compound which reacts with the 4-aminoantipyrine and hydrogen peroxide to form the chromogen. The phenol is added in an amount sufficient to react with the hydrogen peroxide formed and the 4-aminoantipyrine. The resultant enzyme concentrate solution is diluted with water prior to use in a total cholesterol assay. The concentrate solution is stable for about six months at room temperature when kept from light. The concentrate prior to use can be diluted with distilled water generally in a ratio of about one part concentrate to about four parts water. The resulting solution is stable about 6 to 12 months at 40C and two to three months at room temperature. In the oxygen-consumption method of total cholesterol assay, only one enzyme reagent is needed which is an enzyme concentrate or final diluted enzyme reagent may also be used with one year stability at 40C. As oxygen consumption is measured to determine the quantitative amount of total cholesterol present in the serum sample, there is no need for a chromogen agent in the solution, nor is there a need for two separate solutions. The stabilized solution herein for use in the oxygen consumption analysis of total cholesterol is prepared by dissolving the sodium salt or cholic acid, such as sodium cholate, in a buffer solution having a pH range of about 4 to about 9. The buffer solution can be the buffer solution described above with regard to the total cholesterol assay using spectrophoto- metric analysis. After dissolvin(J ttie sodium cholate in the buffer solution, cholesterol esterase is added and dissolved. The resulting mixture is allowed to stand under refrigeration conditions (2 to 80C) for about 24 hours to insure dissolving the components. The mixture is thoroughly intermixed to provide a homogeneously opaque solution. The cholesterol esterase used can be any cholesterol esterase, but is preferably a cholesterol esterase from a microorganism as cholesterol esterases from animal sources do not have the stability of cholesterol esterases from microorganisms. As discussed above with regard to the cholesterol esterase used in the spectrophotometric analysis of total cholesterol, it is preferred that the cholesterol esterase be produced from the microorganism pseudomonas fluorescens, ATCC 21156, commercially available from Kyowa Hakko Kogyo Company, Ltd. To the cholesterol esterase buffer solution is added a polyhydroxy compound and TRITON-X-100. The polyhydroxy compound can be a polyhydroxy alcohol, such as glycerol, ethylene glycol and propylene glycol. It is preferred to use glycerol as the polyhydroxy compound. The glycerol is added in an amount that will provide about one-half the volume of the final enzyme concentrate solution. The TRITOl4-X-100 is added in an amount from about 0.1 to about 0.5 percent by weight of the final enzyme concentrate solution. Following the addition oE the polyhydroxy compound and TRITON-X-100, there is added to the solution a cholesterol oxidase. The cholesterol oxidase is first dissolved in a suitable amount of the buffer solution prior to introducing the cholesterol oxidase into the mixture containing the cholesterol esterase, polyhydroxy compound and TRITON-X-100. The cholesterol oxidase can be any suitable cholesterol oxidase but is preferably a cholesterol oxidase produced from a microbial source. Suitable microbial sources for the cholesterol oxidase include pseudomonas sp, nocardia erythropolis and brevibacterium stero licum. The preferred microbial source for the cholesterol oxidase is the microorganism nocardia erythropolis. The cholesterol oxidase can be present in any suitable amount but for economic reasons the amount is limited. Additionally, the amount of cholestero oxidase used depends upon the source of the cholesterol oxidase and the pH of the resulting solution. The cholesterol oxidase produced from nocardia erythropolis is preferred because such cholesterol oxidase retains its maximum activity at a pH within the range of 5 to 9 and retains its activity preferentially within the pH range of 6 to about 8. As the amount of cholesterol oxidase is increased, the time for conducting the cholesterol assay is decreased. Preferably, it is desired to have an amount of cholesterol oxidase such that the reaction sequence leading to the consumption of oxygen is accomplished within a time limit of about 2 to 5 minutes at 370C. The resulting solution provides a stabilized solution which can be used in the oxygen consumption method of assay for total cholesterol in a serum sample. The enzyme concentrate solution has a stability of about two to three years under refrigerated conditions (20 to 80C), and a stability of about six months at room temperature. The fully diluted working solution is stable two to three months at room temperature and 6 to 12 months under refrigeration. The solution has special applicability when used in a Beckman Cholesterol Analyzer 2. The Beckman Cholesterol Analyzer 2 can conduct assay on up to about 50 samples of serum per hour. The instrument can be calibrated using standard reference serums containing known amounts of cholesterol. The volume of the serum and stabilized solution used is approximately 1 milliliter of the stabilized solution, plus approximately 5 to 10 microliters of the serum sample. The sample introduced into the instrument is generally about five microliters in volume The invention is further illustrated by, but not limited to, the following examples. Example I STABILIZED SOLUTIONS FOR TWO-REAGENT ASSAY OF TOTAL CHOLESTEROL BY SPECTROPHOTOMETRIC ANALYSIS The first reagent and stabilized solution was prepared by forming a buffer solution of sodium hydroxide and potassium dihydrogen phosphate. The buffer solution was prepared by dissolving 136 g of potassium dihydrogen phospha in 980 ml of distilled water. To the resultant solution was added 33 g of sodium hydroxide which was thoroughly intermixed and dissolved in the solution. The resulting buffer solution had a pH of about 6.60. To 73 ml of the buffer solution was added 0.75 g of sodium cholate. Added to the buffer solution was- 150 international units (IU) of cholesterol esterase from pseudomonas fluorescens (ATCC 21156), commercially available from Kyowa Hakko Kogyo Company, Ltd. The cholesterol esterase was thoroughly intermixed with the buffer solution and sodium cholate, and the resultant mixture was allowed to stand under refrigerator conditions (20 to 8"C) for about 24 hours. The resultant mixture was a homogeneously opaque solution. To the mixture was added 75 ml of glycerol and 2.25 ml of TRITON-X-100 (scintillation grade) from J. T. Baker Chemical Co. The glycerol and TRITON-X-100 were added simultaneously with stirring to insure thorough intermixing with the buffered cholesterol esterase mixture. Cholesterol oxidase, commercially available from Whatman Chemical Co. and produced from the microorganism nocardia erythropolis,-was dissolved in 1 ml of the buffer solution. An amount of cholesterol oxidase sufficient to provide 75 IU of activity was dissolved in the buffer solution. The resultant solution of cholesterol oxidase was introduced into the cholesterol esterase buffered solution. Peroxidase from horseradish source in an amount sufficient to provide 22.5 KU was dissolved in 1 ml of the buffer solution. The resultant solution was also introduced into the buffered cholesterol esterase mixture. To the buffered enzyme-containing solution was then added 45 my of 4-aminoantipyrine. The solution was then thoroughly intermixed to dissolve the 4-aminoantipyrine. The resulting solution comprised about 150 ml total volume. The enzyme concentrate reagent had the following concentration as formulated: Sodiuni cholate 10 t1 +2% 4-aminoantipyrine 1.5 mM +2 Peroxidase 150,000 IU/1 +5 Cholesterol oxidase 500 IU/1 15% Cholesterol esterase 1,000 IU/1 5 TRITON-X-100 1.5% +2 by volume The second reagent was formulated by dissolving 1.5 g of phenol in 1.5 liters of distilled water. To the phenol water solution was added 1.5 ml of TRITON-X-100 (scintillation grade). The resultant solution was about 1.5 liters in volume and had the following concentration as formulated: TRITON-x-100 0.1% +2% by volume Phenol 10 m +2E Prior to conducting an assay of cholesterol in a serum sample, the two reagents were combined in the following amounts. To each 0.20 ml of the enzyme concentrate reagent was added 0.80 ml of the second reagent. The combined reagents were then thoroughly intermixed by inverting at least 30 times. Thus, the formulated combined reagent had the following concentration as formulated: TRITON-X-100 0.4% by volume Phenol 8 mM Sodium cholate 2 mM 4-aminoantipyrine 0.3 mM Peroxidase 30,000 IU/1 Cholesterol oxidase 100 IU/l Cholesterol esterase 200 IU/1 The combined reagents had an appearance that was clear. The pH, at 250C for the combined reagent, was 6.7 +0.2. The initial absorbance measured at 500 nm was < 0.100. The combined reagents exhibited a linearity of +5 percent up to 1000 mg/dl at 500 nm. The dynamic range of the cbmbined reagents after two years of shelf life at 20 to 80C is estimated to be about 500 mg/dl based on accelerated stability studies at elevated temperatures. The recovery of the activity when compared with commercial lipid control serum PRECILIP was 95 to 105 percent of the theoretical value for the combined reagent. The combined reagents provided a reaction time for assay of total cholesterol in a serum sample of about five to six minutes at 370C. The assay of total cholesterol in a serum sample was conducted using 1.0 ml of the combined reagent with ten microliters of a serum sample. The combined reagent had a stability at room temperature of about three months. The stability at 41 C was about 24 hours, at 20 to 80C stability is estimated to be 6 to 12 months. The stability was measured to the time which would allow recovery of 95 to 105 percent of the cholesterol value of the lipid control serum PRECILIP. Five times the sample volume was used (i.e., 50 p1 of sample per ml of reagent). The uncombined reagents, i.e., the enzyme concentrate reagent exhibited a stability when tested under accelerated conditions of 72 hours at 410C and 10 days at 37"C. Example II STABILIZED ENZYME SOLUTION FOR THE SINGLE REAGENT SPECTROPHOTOMETRIC ASSAY OF TOTAL CHOLESTEROL A buffer solution was prepared using potassium dihydroger phosphate and sodium hydroxide as described in Example I. To 73 ml of the buffer solution was added 0.75 tg of sodium cholate. Also, to the buffer solution was added 150 IIJ of cholesterol esterase from pseudomonas fluorescens (ATCC 21156, The mixture was thoroughly intermixed and allowed to stand under refrigeration (2 to 80C) for about 24 hours. The resulting solution was a homogeneously opaque solution. To the opaque solution was added 75 ml of glycerol and 2.25 ml of TRITON-X-100 (scintillation grade) from J. T. Baker Chemical Co. A cholesterol oxidase available commercially from Whatman Chemical Co. and produced from nocardia erythropolis was dissolved in 1 ml of the buffer solution and introduced into the buffered cholesterol esteras°? solution. The cholesterol oxidase was added in an amount of 75 IU. Additionally, a peroxidase in an amount of 22.5 KU was dissolved in 1 ml of the buffer solution and introduced into the buffered cholesterol esterase solution. The peroxidase was a commercially available peroxdase from horseradish source. The solution containing the cholesterol esterase, cholesterol oxidase and peroxidase was thoroughly intermixed. To the resultant enzyme solution was added 45 mg of 4-aminoantipyrine while mixing this solution to dissolve the 4-aminoantipyrine. Following the addition of the 4-aminoantipyrine, there was added 450 mg of phenol. The resultant solution was thoroughly intermixed to obtain a white, milky solution. The resulting stabilized enzyme reagent had a concentration formulated as follows: Sodium cholate 10 mM +2 4-aminoantipyrine 1.5 MX +2% Peroxidase 150,000 IU/1 +52 Cholesterol oxidase 500 IU/1 +5 Cholesterol esterase 1,000 IU/1 +5% TRITON-X-100 1.5 +2 by volume Phenol 30 mM +2% The above concentrated enzyme reagent solution is reconstituted prior to performing an assay for total cholesterol by dissolving 0.20 ml of the reagent in 0.80 liters of distilled water and mixing well by inverting at least 30 times. The reconstituted solution had a stability at 20 to 80C for about 6 to 12 months. The reconstituted reagent had the following concentration as reconstituted: TRITON-X-100 0.3E by volume Phenol 6 mI > l Sodium cholate 2 mt4 4-aminoantipyrine 0.3 mM Peroxidase 30,000 IU/1 Cholesterol oxidase 100 IU/l Cholesterol esterase 200 IU/1 The above reconstituted reagent had an appearance that was clear and exhibited a pH at 250C of about 6.7 +0.2. The initial absorbance of the reconstituted reagent was < 0.100 at 500 nm. The reconstituted reagent exhibited a linearity at 500 nm of +5 percent up to 1000 mg/dl. The dynamic range for the reconstituted reagent was estimated to be 500 mg/dl after one year storage at 20 to 80C. The recovery of the reactivity for the reconstituted reagent when used to assay 5X the concentration of commercial lipid control serum PRECILIP was 95 to 105 percent of the theoretical value stated for the control (i.e., 50 pl control per 1 ml of reconstituted reagent with a reaction time of ten minutes at 370C. On an accelerated stability study, the reconstituted reagent exhibited a stability after storage for 24 hours at 370C, recovered 95 to 105 percent of the 5X PRECILIP theoretical value. The concentrate reagent alone (undiluted) exhibited a stability of about 72 hours at 41 C and about 10 days at about 370C. The reconstituted reagent provided a reaction time for the assay of total cholesterol of about five to six minutes at 37"C. The assay of total cholesterol was conducted using 1.0 ml of the reconstituted reagent with 10 microliters of the serum sample, or in the case of 5X PRECILIP 50 Ill of PRECILIP was used per 1 ml of reconstituted reagent. Example III The formulating procedure described in Example I was repeated in every essential detail with the exception that the concentration of the components was varied to provide a combined reagent having the following concentration as formulated: Sodium cholate 1.45 raM 4-aminoantipyrine 0.63 tt Phenol 3.98 xni TRITON-X-100 0.038% by volume Peroxidase 50,000 IU/1 Cholesterol oxidase 750 IU/1 Cholesterol esterase 1,000 IU/l The combined reagent exhibited a stability of two months at 20 to 80C. Example IV STABILIZED SOLUTION FOR THE OXYGEN CONSUMPTION ASSAY OF TOTAL CHOLESTEROL A buffer solution is prepared using potassium dihydrogen phosphate and sodium hydroxide as described in example I. The buffer solution has a pH of about 6.60. To 925 ml of the buffer solution is added 0.75 g of sodium cholate and 1000 IU of cholesterol esterase. The cholesterol esterase is from pseudolnonas fluorescens (ATCC 21156). The resultant mixture is allowed to stand under refrigerated conditions (2 to 8 C) for 24 hours to allow thorough mixing and solvation of the sodium cholate and cholesterol esterase. The resulting mixture is a homogeneously opaque solution having no large particles visible. To the buffered cholesterol esterase solution is added 75 ml of glycerol and 2.25 ml of TRITON-X-100 (scintillation grade). A cholesterol oxidase in an amount of about 1000 IU is dissolved in 1 ml of the buffer solution and the resultant solution introduced into the buffered cholesterol esterase solution. The resultant solution is thoroughly intermixed. The resulting solution provides a stabilized enzyme solution which can be used in the oxygen consumption assay of total cholesterol in a serum sample. The solution has a concentration formulated as follows: Sodium cholate 10 mM 2% Cholesterol oxidase 1000 IU/1 +5% Cholesterol esterase ^1000 IU/1 +5 TRITON-X-100 0.225% *0.2% by volume Buffer 0.6-0.8 Molar The stabilized solution has a stability which, when measured by accelerated temperature study to the time that would allow retention of 95 to 105 percent of the cholesterol value of 5X PRECILIP, of about two to three years under refrigerated conditions, about three months at room temperature, 3 days at 370C and about 24 hours at 41"C. The solution has utility in the oxygen consumption assay of total cholesterol in a serum sample when used in combination with a Beckman Cholesterol Analyzer 2. Approximately 1 ml of the solution is used in the instrument for determining total cholesterol. The serum sample to be tested is about 5 microliters which is introduced into the 1 ml of stabilized enzyme solution. Example V STABILIZED ENZYME CONCENTRATE SOLUTION FOR THE OXYGEN CONSUMPTION ASSAY OF TOTAL CHOLESTEROL A buffer solution is prepared using potassium dihydrogen phosphate and sodium hydroxide as described in Example I. The buffer solution has a pH of about 6.60. To 73 ml of the buffer solution is added 0.75 g of sodium cholate and 150 IU of cholesterol esterase from pseudomonas fluorescens (ATCC 21156). The resultant mixture is allowed to stand under refrigerated conditions (2 to 80C) for 24 hours to allow thorough mixing and solvation of the sodium cholate and cholesterol esterase. The mixture is a homogeneously opaque solution with no large particles visible. To the buffered cholesterol esterase solution is added 75 ml of glycerol and 2.25 ml of TRITON-X-100 (scintillation grade). A cholesterol oxidase in an amount of about 150 IU is dissolved in 1 ml of the buffer solution and added to the buffered cholesterol esterase solution. The solutions are thoroughly mixed. The resulting solution provides a stabilized enzyme concentrate solution which, upon dilution with a buffer solution and/or water, can be used in the oxygen consumption assay of total cholesterol in a serum sample. The concentrate has concentration after dilution as follows: Sodium cholate 10 rn1 +2% Cholesterol oxidase 1000 IU/l +5% Cholesterol esterase 1000 IU/l +5% TRiTON-X-100 0.225% +0.28 by volume The stabilized enzyme concentrate solution has utility when diluted with buffer and/or water in the instrumental analysis by oxygen consumption of total cholesterol in a serum sample such as when using a Beckman Cholesterol Analyzer 2. The enzyme concentrate solution is diluted in a ratio of about 1 part concentrate to about 5 to 6 parts diluent. Approximately 1 ml of the diluted solution is used in the instrument for determining total cholesterol. About 5 microliters of the serum sample to be assayed is introduced into 1 ml of the diluted enzyme solution. The assay is then made on this sample.

Claims: WHAT IS CLAIMED IS: 1. A method of stabilizing an enzymic solution for use in the determination of total cholesterol, the method comprising the steps of: (a) dissolving a metal salt of cholic acid in a buffer solution having a pH range of about 4 to 9; (b) dissolving cholesterol esterase in the buffered salt solution; (c) adding a polyhydroxy organic compound to the solution; (d) adding a surfactant to the solution; (e) dissolving cholesterol oxidase in a sufficient amount of buffer solution and adding the dissolved cholesterol oxidase to the solution; (f) dissolving peroxidase in a sufficient amount of buffer solution and adding the dissolved peroxidase to the solution; and (g) dissolving 4-aminoantipyrine in the solution. 2. A method of stabilizing an enzymic solution for use in the determination of total cholesterol, the method comprising the steps of: (a) preparing a buffer solution having a pH range of about 4 to 9; (b) dissolving sodium cholate in a portion of the buffer solution; (c) dissolving cholesterol esterase in the portion of the buffer solution; (d) adding a polyhydroxy organic compound to the buffer solution; (e) adding a surfactant to the buffer solution; (Claim 2 cont.) (f) dissolving cholesterol oxidase in a sufficient amount of a remaining portion of the buffer solution and adding the dissolved cholesterol oxidase to the portion of buffer solution containing cholesterol esterase; ; (g) dissolving peroxidase in a sufficient amount of remaining portion of the buffer solution and adding the dissolved peroxidase to the portion of buffer solution containing cholesterol esterase. (h) dissolving 4-aminoantipyrine in the portion of buffer solution containing cholesterol esterase; and (i) adding phenol to the buffer solution containing cholesterol esterase. 3. A method of preparing a two solution, total cholesterol assay kit, the method comprising the steps of: (a) preparing a buffer solution having a range of about 4 to 9; (b) preparing a first solution of enzyme concentrate by dissolving sodium cholate, cholesterol esterase, a polyhydroxy organic compound, and adding a surfactant in a first portion of the buffer solution, dissolving cholesterol oxidase in a second portion of buffer solution and adding the dissolved cholesterol oxidase to the portion of buffer solution containing cholesterol esterase, dissolving peroxidase in a third portion buffer solution and adding the dissolved peroxidase to the portion of buffer solution containing cholesterol esterase, and dissolving 4-aminoantipyrine in the portion of buffer solution containing cholesterol esterase; and (c) preparing a second solution of chromogen diluent by dissolving phenol and adding a surfactant in a fourth portion of buffer solution. 4. A method of stabilizing an enzymic solution for use in the oxygen consumption assay of total cholesterol, the method comprising the steps of: (a) preparing a buffer solution having a pH range of about 4 to 9; (b) dissolving a metal salt of cholic acid in a first portion of the buffer solution; (c) dissolving cholesterol esterase in the first portion of buffer solution; (d) adding a polyhydroxy organic compound to the first portion of buffer solution; (e) adding a surfactant to the first portion of buffer solution; and (f) dissolving cholesterol oxidase in a second portion of the buffer solution and adding the dissolved cholesterol oxidase to the first portion of buffer solution. 5. A method as recited in claim 1, 2, 3 or 4 wherein the cholesterol esterase is from the microorganism pseudomonas fluorescens ATCC 21156. 6. A method as recited in claim 1, 2, 3 or 4 wherein the cholesterol oxidase is recovered from a microorganism selected from the group consisting of pseudomonas sp, nocardia erythropolis, and brevibacterium stero licum. 7. A method as recited in claim 1, 2, 3 or 4 wherein the peroxidase is from horseradish source. 8. A method as recited in claim 1, 2, 3 or 4 wherein the polyhydroxy organic compound is selected from the group consisting of glycerol, ethylene glycol sorbitol and propylene glycol. 9. A method as recited in claim 1, 2, 3 or 4 wherein the buffer is a potassium dihydrogen phosphate and sodium hydroxide providing a pH range of about 6 to 8. 10. A method as recited in claim 1 or 4 wherein the metal salt of cholic acid is sodium cholate. 11. A method as recited in claim 1, 2, 3 or 4 wherein the salt of cholic acid is added in an amount up to about 2.25 g for each 150 ml of final volume of the stabilized solution. 12. A method as recited in claim 1, 2, 3 or 4 wherein the cholesterol esterase is provided at least in an amount sufficient to complete the deesterification of cholesterol esters in a time of about ten minutes at a temperature of about 370C. 13. A method as recited in claim 1, 2, 3 or 4 wherein the polyhydroxy compound is present in an amount up to about one-half of the volume of the solution. 14. A method as recited in claim 1, 2, 3 or 4 wherein the surfactant is provided in an amount from about 0.5 to about 2.5 percent by volume of the stabilized solution. 15. A method as recited in claim 1, 2, 3 or 4 wherein the cholesterol oxidase is produced from nocardia erythropolis and the pH of the solution is from about 6 to about 8. 16. A method as recited in claim 1, 2, 3 or 4 wherein the cholesterol oxidase is produced from pseudomonas sp and the pH of the solution is about 4 to 7. 17. A method as recited in claim 1, 2, 3 or 4 wherein the cholesterol oxidase is produced from brevibacterium stero licum and the pH of the solution is about 5 to 7. 18. A method as recited in claim 1, 2, 3 or 4 wherein the cholesterol oxidase is provided in an amount of about 500 to about 750 IU/liter. 19. A method as recited in claim 1, 2, 3 or 4 wherein the 4-aminoantipyrine is provided in an amount from about 22.5 to about 67.5 mg per 150 ml of stabilized solution. 20. A method as recited in claim 2 or 3 wherein the phenol is provided in an amount from about 0.75 to about 2.25 g per 150 ml of solution. 21. A stabilized enzymic solution for use in the assay of total cholesterol and prepared by the method of claim 1, 2 or 4. 22. A stabilized enzymic solution and diluent solution for use in the assay of total cholesterol and prepared by the method of claim 3. 23. A kit for use in assaying total cholesterol in a sample comprising: (a) a stabilized enzyme concentrate solution comprising an aqueous buffer solution providing a pH of about 4 to about 9 and containing a metal salt of cholic acid cholesterol esterase, cholesterol oxidase, peroxidase, a surfactant, a polyhydroxy organic compound, and 4-aminoantipyrine; and (b) a chromogen diluent solution comprising an aqueous solution containing phenol and surfactant. 24. A kit as recited in claim 23 wherein the stabilized enzyme concentrate solution comprises 75 ml of a buffer solution providing a pH of about 6.60, 0.75 g of sodium cholate, 150. IU of cholesterol esterase, 75 ml of glycerol, 2.25 ml of surfactant, 75 IU of cholesterol oxidase, 22.5 KU peroxidase and 45 mg of 4-aminoantipyrine and the chromogen diluent solution comprises 1.5 g of phenol, 1.5 ml of surfactant and 1.5 liters of water. 25. A kit for use in assaying total cholesterol in a sample comprising a stabilized enzyme concentrate solution which is diluted with water in a ratio of about one part enzyme solution to four parts water prior to conducting an assay, the solution comprising 75 ml of a buffer solution providing a pH of about 6.60, 0.75 g of sodium cholate, 150 IU of cholesterol esterase, 75 ml of glycerol, 2.25 ml of surfactant, 75 IU cholesterol oxidase, 22.5 KU peroxidase, 45 mg of 4-aminoantipyrine and 450 mg of phenol. 26. A kit for use in the oxygen consumption assay of total cholesterol in a sample comprising a stabilized enzyme solution comprising 925 ml of a buffer solution providing a pH range of about 6.6, 0.75 g of sodium cholate, 1000 IU cholesterol esterase, 75 ml glycerol, 2.25 ml of surfactant, and 1000 IU cholesterol oxidase. 27. A kit for use in the oxygen consumption assay of total cholesterol in a sample comprising a stabilized enzyme concentrate solution which can be diluted with water in a ratio of one part enzyme concentrate to four parts water, the stabilized enzyme concentrate solution comprising 75 ml of a buffer solution providing a pH of about 6.6, 0.75 g of sodium cholate and 800 IU cholesterol esterase, 75 ml glycerol, 2.25 ml surfactant, and 1000 IU cholesterol oxidase. 28. A kit as recited in claim 23, 24, 25, 26 or 27 wherein the cholesterol esterase is from pseudomonas fluorescens. 29. A kit as recited in claim 23, 24, 25, 26 or 27 wherein the cholesterol oxidase is from nocardia erythropolis. 30. A stabilized solution as recited in claim 1, 2, 3, 4, 14, 23, 24, 25, 26 or 27 wherein the surfactant is Triton X-100.

Inventors: MODROVICH, IVAN ENDRE
Applicants: MODROVICH, IVAN ENDRE
Application year: 1980
Main classification: C12Q1
IPC codes: G01N33, C12Q1, C12N9